Canopy Biosciences, founded in 2016 and headquartered in Saint Louis, Missouri, offers a comprehensive portfolio of products and services for gene editing, gene expression analysis, and bioprocessing. They partner with researchers to turn their discoveries into tangible products and aim to accelerate the commercialization of life science reagent tools and services in the fields of genetic engineering and personalized medicine. Recently, Canopy Biosciences was acquired by Bruker, a provider of spatial biology and multi-omic tools, in a transaction whose terms were not disclosed.